Ticker Symbol: ALNY
Alnylam Pharmaceuticals Inc
$172.94 - 20-12-2024 4 p.m. ET
Exchange: NASDAQ
Country:
US
Currency:
USD
Asset
Type: Common Stock
CIK:0001178670
Company Profile
alnylam is developing an entirely new class of innovative medicines based on a breakthrough discovery in biology known as rna interference, or rnai. with rnai technology, we have the opportunity to treat disease and impact the lives of patients in a fundamentally new way by silencing disease-causing genes upstream of today's medicines.
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: 675 W Kendall St
Website: https://www.alnylam.com/
CEO: John Maraganore
Tags:
- Health Technology
- Biotechnology
- Manufacturing
- Pharmaceutical Preparation Manufacturing
Pricing
Last Updated: October 20, 2023 03:00 PM EST
Previous Close: $161.79
Change:
$1.29
(
0.80%)
Days Range: $159.50 - $163.52
Beta: -
52wk. High: $242.97
52wk. Low: $159.47
Ytd. Change -31.12%
50 Day Moving Average: $178.30
200 Day Moving Average: $191.63
Shares Outstanding: 125000652
Valuation
Market Cap: 2.0T
PE Ratio: -18.79
EPS (TTM): -8.61
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A